Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GLATIRAMER vs GLIMEPIRIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GLATIRAMER vs GLIMEPIRIDE: Safety Overview

Metric GLATIRAMER GLIMEPIRIDE
Total FAERS Reports 46,357 5,572
Deaths Reported 696 552
Death Rate 1.5% 9.9%
Hospitalizations 5,831 2,550
Average Patient Age 48.4 yrs 66.6 yrs
% Female Patients 81.0% 46.4%
FDA Approval Date Apr 16, 2015 Apr 17, 2013
Manufacturer Zydus Pharmaceuticals USA Inc. A-S Medication Solutions
Route SUBCUTANEOUS ORAL
Marketing Status Discontinued Discontinued